Save time and jump to the most important pieces.
| Company | Date | Price Target | Rating | Analyst |
|---|---|---|---|---|
| 10/11/2024 | $70.00 | Equal-Weight | Morgan Stanley | |
| 10/10/2024 | $245.00 → $230.00 | Overweight → Equal Weight | Wells Fargo | |
| 9/18/2024 | $85.00 → $70.00 | Buy → Hold | Jefferies | |
| 8/1/2024 | Neutral | Northcoast | ||
| 7/31/2024 | Neutral → Outperform | Daiwa Securities | ||
| 7/29/2024 | Underperform → Peer Perform | Wolfe Research | ||
| 7/25/2024 | $100.00 → $70.00 | Buy → Hold | TD Cowen | |
| 7/25/2024 | $105.00 → $75.00 | Buy → Neutral | BofA Securities |
CLEVELAND, Nov. 7, 2024 /PRNewswire/ -- TransDigm Group Incorporated (NYSE:TDG), a leading global designer, producer and supplier of highly engineered aircraft components, today reported results for the fourth quarter ended September 30, 2024. Fourth quarter highlights include: Net sales of $2,185 million, up 18% from $1,852 million in the prior year's quarter;Net income of $468 million, up 13% from the prior year's quarter;Earnings per share of $5.80;EBITDA As Defined of $1,149 million, up 19% from $963 million in the prior year's quarter;EBITDA As Defined margin of 52.6%; an
On September 12, 2024, American Tower Corporation (the "Company" or "American Tower") completed the sale of 100% of the equity interests in its operations in India ("ATC TIPL" or "ATC India") to Data Infrastructure Trust, an Infrastructure Investment Trust sponsored by an affiliate of Brookfield Asset Management (the "ATC TIPL Transaction"). The ATC TIPL Transaction qualified for presentation as discontinued operations. Prior to the divestiture and classification as discontinued operations, ATC TIPL's operating results were included within the Asia-Pacific property segment. Accordingly, the operating results of ATC TIPL are reported as discontinued operations for all periods presented. Plea
CLEVELAND, Oct. 28, 2024 /PRNewswire/ -- TransDigm Group Incorporated (NYSE:TDG) today said it will report fiscal 2024 fourth quarter earnings before the market opens on Thursday, November 7, 2024. A conference call will follow at 11:00 a.m., Eastern Time. To join the call telephonically, please register for the call here. Once registered, participants will receive the dial-in information and a unique pin to access the call. A live audio webcast of the call can also be accessed online at http://www.transdigm.com. The webcast will be archived on the website and available for re
Morgan Stanley resumed coverage of Edwards Lifesciences with a rating of Equal-Weight and set a new price target of $70.00
Wells Fargo downgraded American Tower from Overweight to Equal Weight and set a new price target of $230.00 from $245.00 previously
Jefferies downgraded Edwards Lifesciences from Buy to Hold and set a new price target of $70.00 from $85.00 previously
4 - TransDigm Group INC (0001260221) (Issuer)
4 - TransDigm Group INC (0001260221) (Issuer)
4 - TransDigm Group INC (0001260221) (Issuer)
8-K - AMERICAN TOWER CORP /MA/ (0001053507) (Filer)
8-K - AMERICAN TOWER CORP /MA/ (0001053507) (Filer)
424B5 - AMERICAN TOWER CORP /MA/ (0001053507) (Filer)
SC 13G - Edwards Lifesciences Corp (0001099800) (Subject)
SC 13G/A - Edwards Lifesciences Corp (0001099800) (Subject)
SC 13G/A - Edwards Lifesciences Corp (0001099800) (Subject)
Edwards Lifesciences (NYSE:EW) today announced one-year data highlighting the continued outstanding performance of its SAPIEN 3 Ultra RESILIA valve. The data were presented at PCR London Valves 2024 and simultaneously published in the Journal of the American College of Cardiology (JACC): Cardiovascular Interventions. An analysis of data from more than 9,000 propensity-matched patients in the STS/ACC TVT Registry1 demonstrated that those who received Edwards' newest generation SAPIEN 3 Ultra RESILIA valve experienced outstanding one-year outcomes that continuously surpassed recipients of the earlier generation SAPIEN 3 and SAPIEN 3 Ultra valves. Patients receiving the SAPIEN 3 Ultra RESILI
American Tower Corporation (NYSE:AMT) today announced the pricing of its registered public offering of senior unsecured notes due 2030 and 2035 in aggregate principal amounts of $600.0 million and $600.0 million, respectively. The 2030 notes will have an interest rate of 5.000% per annum and are being issued at a price equal to 99.622% of their face value. The 2035 notes will have an interest rate of 5.400% per annum and are being issued at a price equal to 99.455% of their face value. The net proceeds of the offering are expected to be approximately $1,183.7 million, after deducting underwriting discounts and estimated offering expenses. American Tower intends to use the net proceeds to
CLEVELAND, Nov. 7, 2024 /PRNewswire/ -- TransDigm Group Incorporated (NYSE:TDG), a leading global designer, producer and supplier of highly engineered aircraft components, today reported results for the fourth quarter ended September 30, 2024. Fourth quarter highlights include: Net sales of $2,185 million, up 18% from $1,852 million in the prior year's quarter;Net income of $468 million, up 13% from the prior year's quarter;Earnings per share of $5.80;EBITDA As Defined of $1,149 million, up 19% from $963 million in the prior year's quarter;EBITDA As Defined margin of 52.6%; an
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Citigroup analyst Paul Lejuez downgraded the rating for Lululemon Athletica Inc. (NASDAQ:LULU) from Buy to Neutral, while cutting the price target from $415 to $300. Lululemon shares settled at $272.06 on Wednesday. See how other analysts view this stock. See how other analysts view this stock. Argus Research analyst Kevin Heal downgraded Zions Bancorporation (NASDAQ:ZION) from Buy to Hold. Zions Bancorp shares closed at $50.98 on Wednesday. See how other analysts view this stock. B
Stifel analyst Rick Wise maintains Edwards Lifesciences (NYSE:EW) with a Hold and lowers the price target from $85 to $70.
Oppenheimer analyst Suraj Kalia maintains Edwards Lifesciences (NYSE:EW) with a Outperform and lowers the price target from $100 to $90.
4 - TransDigm Group INC (0001260221) (Issuer)
4 - TransDigm Group INC (0001260221) (Issuer)
4 - Edwards Lifesciences Corp (0001099800) (Issuer)
Waives Option to Classify Board Under Maryland Law Independence Realty Trust, Inc. (NYSE:IRT) ("IRT" or the "Company") today announced the appointment of Craig Macnab to its Board of Directors (the "Board"), effective February 29, 2024. Mr. Macnab brings over 20 years of experience to IRT's Board after serving in various executive and board roles in the REIT industry, including most recently as CEO of National Retail Properties, Inc. (NYSE:NNN) for 13 years. Mr. Macnab's appointment increases the size of IRT's Board to 10 members, including 8 independent directors. In connection with this announcement, the Company has entered into a cooperation agreement with Argosy-Lionbridge Management,
Charge Enterprises, Inc. (NASDAQ:CRGE) ("Charge" or the "Company"), announced today its Board of Directors has appointed Jacky Wu as an independent director, effective June 16, 2023. Mr. Wu's appointment expands the Board to ten members, six of whom are independent directors. Mr. Wu is currently the Executive Vice President and Chief Financial Officer of DigitalBridge Group, Inc., a global digital infrastructure investment firm (NYSE:DBRG). Prior to joining DigitalBridge, Mr. Wu was Executive Vice President and Chief Financial Officer of Driven Brands, Inc. (NASDAQ:DRVN), North America's largest automotive aftermarket platform. Prior to Driven Brands, Mr. Wu was Executive Vice President and
CLEVELAND, May 26, 2023 /PRNewswire/ -- TransDigm Group Incorporated (NYSE:TDG) ("the Company") announced today the upcoming retirement of Chief Operating Officer Jorge L. Valladares III, the appointment of Mr. Valladares to the Company's Board of Directors, the appointment of Mike Lisman and Joel Reiss as Co-Chief Operating Officers, and the appointment of Sarah Wynne as Chief Financial Officer. Retirement of Chief Operating Officer Jorge L. Valladares III Mr. Valladares will retire at the end of the TransDigm's 2023 fiscal year and has served as the Company's Chief Operatin